Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Shares Hit 52-Week High

Shares in Bruker BioSciences briefly climbed to a 52-week high of $5.70 this week, before closing up 11.75 percent to $5.61 on Tuesday. The firm's shares rose this past week after announcing a biodefense contract for the United Arab Emirates. Molecular Devices also hovered near a 52-week high, closing up 8.89 percent for the tracking period ended Tuesday.

Harvard Bioscience led decliners for the week, closing the period down 7.39 percent.

Overall, the BCW Index closed up 1.89 percent, while the Nasdaq rose 1.77 percent, the Nasdaq Biotech Index gained .2 percent, and the Dow Jones Industrial Average rose .4 percent.

BioCommerce Week Index of Diversified Molecular Biology Tool Companies
Company
Ticker
Current Price
(Apr. 4, 2006)
Last Price
(Mar. 28, 2006)
% change
Agilent
A
38.05
36.27
4.91
Applied Biosystems
ABI
27.09
27.52
-1.56
Beckman
BEC
54.21
54.68
-0.86
Bio-Rad
BIO
62.74
58.51
7.23
Bruker
BRKR
5.61
5.02
11.75
Fisher Scientific
FSH
68.16
68.81
-0.94
GE
GE
34.7
33.6
3.27
Harvard Bio
HBIO
4.01
4.33
-7.39
Invitrogen
IVGN
68.24
70.72
-3.51
Molecular Devices
MDCC
34.29
31.49
8.89
PerkinElmer
PKI
23.4
23.15
1.08
Qiagen
QGEN
14.53
14.63
-0.68
Sigma
SIAL
66.6
64.32
3.54
Stratagene
STGN
10.72
10.29
4.18
Thermo
TMO
36.96
36.12
2.33
Waters
WAT
43.95
42.79
2.71
BCW Index Average
37.08
36.39
1.89
The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.